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Abstract
Background: Targeting the biosynthetic pathway of Coenzyme A (CoA) for drug development will compromise multiple
cellular functions of the tubercular pathogen simultaneously. Structural divergence in the organization of the penultimate
and final enzymes of CoA biosynthesis in the host and pathogen and the differences in their regulation mark out the final
enzyme, dephosphocoenzyme A kinase (CoaE) as a potential drug target.
Methodology/Principal Findings: We report here a complete biochemical and biophysical characterization of the M.
tuberculosis CoaE, an enzyme essential for the pathogen’s survival, elucidating for the first time the interactions of a
dephosphocoenzyme A kinase with its substrates, dephosphocoenzyme A and ATP; its product, CoA and an intrinsic yet
novel inhibitor, CTP, which helps modulate the enzyme’s kinetic capabilities providing interesting insights into the
regulation of CoaE activity. We show that the mycobacterial enzyme is almost 21 times more catalytically proficient than its
counterparts in other prokaryotes. ITC measurements illustrate that the enzyme follows an ordered mechanism of substrate
addition with DCoA as the leading substrate and ATP following in tow. Kinetic and ITC experiments demonstrate that
though CTP binds strongly to the enzyme, it is unable to participate in DCoA phosphorylation. We report that CTP actually
inhibits the enzyme by decreasing its Vmax. Not surprisingly, a structural homology search for the modeled mycobacterial
CoaE picks up cytidylmonophosphate kinases, deoxycytidine kinases, and cytidylate kinases as close homologs. Docking of
DCoA and CTP to CoaE shows that both ligands bind at the same site, their interactions being stabilized by 26 and 28
hydrogen bonds respectively. We have also assigned a role for the universal Unknown Protein Family 0157 (UPF0157)
domain in the mycobacterial CoaE in the proper folding of the full length enzyme.
Conclusions/Significance: In view of the evidence presented, it is imperative to assign a greater role to the last enzyme of
Coenzyme A biosynthesis in metabolite flow regulation through this critical biosynthetic pathway.
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Introduction
Mycobacterium tuberculosis, the causative organism of tuberculosis,
possesses a thick, hydrophobic, complex cell envelope composed of
a variety of complex lipids, peptidoglycans etc. which serves as an
impervious barrier to drugs [1–3]. An excellent means to combat
the pathogen is to target biosynthetic pathways of vitamins and
cofactors which are indispensable in varied cellular functions [4,5].
One such ubiquitous cofactor is Coenzyme A (CoA) which along
with its precursor, 49-phosphopantetheine, functions as an acyl
group carrier and carbonyl activating group for Claisen reactions
as well as for amide-, ester-, and thioester-forming reactions in the
cell acting as prosthetic groups of carrier proteins of fatty acid,
polyketide, nonribosomal peptide synthases etc. [6]. A survey of
the BRENDA database (http://www.brenda-enzymes.info) of all
known enzyme activities shows that 9% of the approximately 3500
identified activities use CoA or a CoA thioester as a co-substrate
and therefore, the ratio between CoA and its thioester derivatives
is important for maintaining cellular homeostasis [7]. This is
further corroborated by the fact that all attempts to disrupt the
genes coding for the enzymes in the CoA biosynthetic pathway
have either failed or have resulted in lethal phenotypes in many
organisms.
CoA biosynthesis, a five-step pathway which utilizes the precursors,
pantothenate, cysteine and ATP, is invariant in all organisms [6]. It
begins with the phosphorylation of pantothenate by the enzyme
CoaA (pantothenate kinase). CoaB (phosphopantethenoylcysteine
synthetase) condenses the 49-phosphopantothenate thus generated
with a cysteine molecule to form 49-phosphopantothenoylcysteine
which is further decarboxylated by CoaC (phosphopantothenoylcys-
teine decarboxylase) liberating 49-phosphopantetheine, the prosthetic
group incorporated by carrier proteins in fatty acid, polyketide,
nonribosomal peptide biosyntheses. CoaD (phosphopantetheine
adenylyltransferase) adenylates the 49-phosphopantetheine moiety
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to generate the final CoA precursor, dephosphocoenzyme A (DCoA).
CoaE (dephosphocoenzyme A kinase, EC 2.7.1.24) then phosphor-
ylates the 39-OH of the ribose in the DCoA structure to generate
CoA.
In mammals, the activities of the penultimate enzyme CoaD
and the final enzyme CoaE are carried out by a single bifunctional
62 kDa enzyme, encoded by the CoA synthase gene [8,9]. The
human and porcine CoA synthases have been shown to possess
three domains, an N-terminal domain that helps target the
bifunctional enzyme to the mitochondrial outer membrane and
mediates protein-protein interactions, a middle CoaD domain and
a C-terminal CoaE domain [10]. Interestingly, it has been shown
that proteolytic cleavage of the human enzyme does not affect
enzyme activity or the proposed tertiary structure [11]. Also, the
N-terminal domain of the CoA synthase is found only in higher
eukaryotes and has been shown to effect regulation of the CoaD
and CoaE activities by phospholipids [12]. The amalgamation of
the last two enzyme activities also hints at the existence of a
currently-unknown, relatively recently evolved mechanism of
regulation of the CoA biosynthetic pathway seen only in the
higher eukaryotes. The mycobacterial enzyme shows a very low
sequence similarity (15%) to the human CoaE. Thus low sequence
homology and different mechanisms of regulation in the
prokaryotic and eukaryotic sequences show that selective inhibi-
tion of the mycobacterial CoA biosynthesis is possible, marking out
dephosphocoenzyme A kinase (CoaE) as a potential antimyco-
bacterial drug target.
Unlike the first step of mycobacterial CoA biosynthesis [13–15],
information about its last step, catalyzed by CoaE, is scanty. Here
we report a complete biochemical and biophysical characteriza-
tion of the putative M. tuberculosis dephosphocoenzyme A kinase
(Rv1631) detailing the kinetic parameters of catalysis, the
energetics and order of substrate binding to the enzyme and the
phosphate donor specificity of the kinase. We show that its activity
is regulated by an intrinsic cellular metabolite, cytidine triphos-
phate (CTP) a feature as yet unknown for members of this family
of enzymes. The mycobacterial enzyme is atypical compared to its
counterparts in the prokaryotic kingdom as it possesses an extra
domain C-terminal to the dephosphocoenzyme A kinase, which
belongs to the Unknown Protein Family, UPF0157 (Pfam
database); to which no function has been assigned till date. We
show that this domain is essentially required for the proper folding
of the mycobacterial CoaE, delineating region 35–50 (KIACGH-
KALRVDHIG) of this domain as essential for the latter function.
Materials and Methods
Plasmid Construction, Expression and Purification of
CoaE
The full length CoaE gene was amplified from M. tuberculosis
genomic DNA using the primers CoaE_Fwd:59- GGAATTCCA-
TATGGTGACCGACCGCGAT–39 and CoaE_Rev:59- CCCA-
AGCTTTTAACGCAAATGCAC-39, designed with NdeI/Hin-
dIII sites. The resulting amplification product was subcloned into
the NdeI/HindIII sites of the pET28a+ expression vector for
recombinant expression in E. coli BL21 (DE3) competent cells.
Sequencing the putative clone using T7 promoter and terminator
helped confirm the final clone. For optimal yield of the
hexahistidine-tagged recombinant protein, cells were grown at
37uC to an O.D600,0.7 and induced with 0.1 mM isopropyl-1-
thio-b-D-galactopyranoside (IPTG) for 8 h at 18uC. The cells
were harvested, resuspended in binding buffer (10 mM Tris-HCl,
500 mM NaCl, 10% glycerol, pH 7.8) and lysed by sonication
twice for 10 min on ice. The cell free lysate was loaded onto
charged Ni- NTA affinity resin (Novagen) and eluted with
100 mM imidazole. The eluted protein was dialyzed against
standard buffer (10 mM Tris, 150 mM NaCl, 5% glycerol,
pH-7.8) and concentrated.
Enzyme Assays
All enzyme assays were carried out at 25uC. Units of activity
correspond to 1 umol of product formed/min, and any blank rates
without DCoA, taken as controls, were subtracted. CoaE activity
was assayed using two different coupled assays; the established
double coupled pyruvate kinase/lactate dehydrogenase (PK/
LDH) and a single-coupled a-ketoglutarate dehydrogenase
(KDH) assay [16]. The latter assays for CoA formation by
monitoring an increase in absorbance at 340 nm due to NADP+
reduction. Each reaction mixture for the a-KDH assay contained
ATP (10 mM), DCoA (0.5 mM), MgCl2 (10 mM), KCl (20 mM),
a-ketoglutarate dehydrogenase (2 U), a-ketoglutarate (2 mM),
NADP (0.3 mM), thiamine pyrophosphate (0.3 mM) in 50 mM
Tris, pH 8.0. Enzyme activity was further confirmed by separating
the products of the reaction mixture containing DCoA (0.25 mM),
ATP (0.25 mM), cP32-ATP (0.5 uCi), MgCl2 (10 mM), DTT
(1.5 mM) in 50 mM Tris, pH 8.0, by descending paper chroma-
tography on a Whatman 3 MM paper in a developing system
containing isobutyric acid:0.5 N ammonium hydroxide (100:60)
and 1 mM EDTA.
ITC Experiments
Since we assayed the enzyme using coupled assays which could
be prone to errors that could account for the high affinity of the
mycobacterial enzyme for its substrates and the higher catalytic
efficiency, compared to its other prokaryotic counterparts, we
chose to quantify the kinetic parameters also using a direct,
thermodynamic approach (Table 1). A thermodynamically
favorable reaction is accompanied by a decrease in free energy
(2DG), which is composed of enthalpic and entropic terms
(DG =DH2TDS). Calorimetry measures the heat exchanged
during any reaction [17]. The high sensitivity of the technique
allows experiments to be carried out with low amounts of enzyme
and a single experiment allows rate calculations multiple times as
several injections of the substrate into the cell containing the
enzyme can be carried out. ITC experiments were performed
using a VP-ITC titration microcalorimeter (Microcal Inc., U.S.A.).
The reference cell was filled with water and the calorimeter was
calibrated using standard electrical pulses as recommended by the
manufacturer. For all ITC experiments, the CoaE protein was
dialyzed overnight (12–18 hr) in 10 mM Tris buffer, pH 7.8,
150 mM NaCl, 10 mM MgCl2, 20 mM KCl and 5% glycerol.
Substrate solutions were prepared in the final dialysis buffer.
Solutions of the protein were filled in the sample cell (1.4 ml) and
titrated with ATP-cS (a non-hydrolysable analog of ATP) or
DCoA solutions introduced into it from the syringe (298 uL).
Excepting the substrate against which the parameters were being
determined, the composition of the solutions in the syringe and cell
were kept constant. ITC experiments were routinely performed at
20uC. Raw data were collected for substrate heats of dilution in the
buffer and integrated using the Microcal Origin software version
7.0 supplied with the instrument. In control experiments, the
substrates were titrated against buffer.
Determination of the Kinetic Parameters of ATP
Hydrolysis by ITC
To evaluate the kinetic parameters of ATP hydrolysis, 1 mM of
dialyzed protein was incubated with 1 mM of DCoA for 45 mins
Mycobacterial CoaE
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on an end-on rocker at 4uC for saturation. The reaction was
started by injecting 20 ml of the 1 mM ATP solution into the
sample cell loaded with DCoA-saturated CoaE. A single injection
of 1 mM ATP (20 ml), prepared in the final dialysis buffer, was
monitored for 3000 seconds. Heat change during the course of
reaction was used to determine the DH for the reaction. To
determine the kinetic constants, the protocol of ligand-multiple
injections was adopted, which also helped ascertain the maximum
velocity for the enzymatic reaction [17]. A gap of 110 seconds was
kept between subsequent injections. Therefore, change in power
(DP) with respect to the added ligand helped determine the kinetic
constants for ATP hydrolysis using following two equations.
vð Þ~ DP
DHVo
and Kcat~
DPmax
DHð Þ Voð Þ Enzyme½ 
where DP is the instant power generated by the reaction, DPmax is
the maximum power generated, DH is the enthalpy change of the
reaction and Vo is the volume of the ITC cell, [Enzyme] is the
concentration of enzyme present in the ITC cell [17]. Kinetic
parameters with respect to DCoA were determined in a similar
fashion as those for ATP.
Kinetics of the Reverse Reaction
In order to determine the kinetic parameters of the reverse
reaction the enzyme was saturated with 1 mM ADP and titrated
against 1 mM CoA. In another set of reactions, the enzyme was
saturated with 1 mM CoA and titrated against 1 mM ADP. For
both the sets of reactions, single as well as multiple injection runs
were carried out as above.
ITC Studies for Substrate Binding to CoaE
Binding studies were carried out with DCoA, CoA, ATP-cS and
ADP. The sample cell was filled with 200 uM CoaE. For each
binding experiment with one substrate, 1 mM solution of the
ligand was introduced from the syringe into the cell containing the
enzyme saturated with the other substrate. For this purpose the
enzyme was incubated with the substrate to be saturated with, on
an end-on rocker for 45 mins, at 4uC. Titrations were carried out
by the stepwise addition of small volumes (10 ul) of the ligand
solution from the constantly stirring syringe (286 rpm) into the
CoaE containing sample cell with a time interval of 180 seconds
between successive injections. Change in the enthalpy (DH), Kb
and n values for the titration were determined by non-linear least
squares fit of the data using Origin Tm 7.0 software. The data
were fitted to a single-site binding model by a non-linear regression
analysis to yield binding constants (Ka), enthalpies of binding (DH)
and the stoichiometry of binding (N).
Mycobacterial CoaE Homology Modeling Studies
No structures are currently available for CoaEs fused to another
domain. In order to aid the selection of modeling templates for the
N- and C-terminal domains of the mycobacterial CoaE, the
Sequence Feature Scan tool from the Swiss-Model was used
(Supporting Information File S1, Table S2) [18]. Putative models
for the NTD and CTD were obtained by the SWISS-MODEL
software of the SWISSPROT workspace using both the first
approach mode as well as the alignment interface mode. Since the
closest homolog, with a solved structure, to the mycobacterial
enzyme, was the E. coli CoaE, we modeled the NTD on the E. coli
structure (32.7% identity, 54.7% similarity). In 2006, a crystal
structure for the GrpB protein of unknown function from
Enterococcus faecalis was deposited in the PDB, (PDB code: 2nrk,
accession no. Q837C3_ENTFA) [19]. This protein also belongs to
the UPF0157 family of proteins of unknown function like the CTD
of the mycobacterial CoaE, with which it shares a sequence identity
of 25.5%. No other crystal structures were available for this domain
except the 2nrk structure and as the CTD shares considerable
sequence similarity with the enterococcal protein (e-value of 4e-48
in PSI-BLAST search), the latter was used as a template to model
the CTD using the Swiss-Model software in the alignment interface
mode. The models of the NTD and CTD thus obtained were then
energy minimized using the Molecular Operating Environment
(MOE) utility, version MOE2006.08, using the MMFF94x force-
field and were then stitched together to generate the modeled
mycobacterial CoaE by the Coot software [20,21]. We extensively
evaluated the model quality using different software (Anolea,
GROMOS, WhatCheck, PROCHECK and ProQres, Supporting
Information File S1). The RMS Z-scores from WhatCheck showed
that the model obtained was acceptable and the Ramachandran
plot showed that the overall conformation of the backbone of the
model was reliable. Fig. S3 shows that the predicted model accuracy
scores lay well within the acceptable range.
Ligand Docking
Ligands used for docking were built using both MOE as well as
the ChemDraw Ultra Version 5.0 software. These were energy
Table 1. Thermodynamic parameters of ligand binding to mycobacterial CoaE at pH 7.8 and 20uC.
Titrant N DH (cal/M21) Ka (M
21*104) DS (calM21K21)
ATP alone 0.683 2495.3 (636.3) 1.18 (60.14) 16.9 (61.21)
DCoA alone 0.810 23719 (6201.5) 1.43 (60.34) 6.32 (60.34)
NHATP binding on DCoA-saturated CoaE 0.947 23776 (6234.5) 2.06 (60.47) 6.85 (60.48)
DCoA binding on NH-ATP-saturated CoaE 0.839 21063 (671.3) 1.85 (60.25) 15.9 (60.91)
CoA alone NB NB NB NB
ADP binding on DCoA-saturated CoaE 1.07 23612 (274.8) 2.03 (60.51) 7.38 (60.78)
ADP binding on CoA-saturated CoaE 1.23 22138 (6181.5) 2.88 (60.58) 13.1 (60.98)
dATP binding on DCoA-saturated CoaE 0.871 2848 (654.7) 1.74 (60.24) 16.4 (61.85)
CTP binding 1.08 2482.5 (637.4) 1.59 (60.19) 17.6 (61.11)
GTP binding NB NB NB NB
Values of DH and DS are in cal mol21K21. Values are the mean of five individual experiments. Ka is the binding constant determined by ITC and its values are in M
21.
doi:10.1371/journal.pone.0007645.t001
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minimized by MOE using the AMBER99 forcefield and then
docked onto the energy minimized protein models using the
MMFF94x forcefield in the MOE server. The docked complex
with the least energy was chosen. Each process starting from
model building, energy minimization and ligand docking was
carried out a minimum of 15 times for each ligand-protein
complex. A detailed analysis of the interatomic contacts, interface
complimentarity for each ligand-protein complex and a putative
list of hydrogen bonds was calculated using the LPC/CSU
software (Tables 2 and 3, Supporting Information File S1) [22].
Cloning, Expression, and Purification of the N-terminal
Domain
The N-terminal 196 amino acid long dephosphocoenzyme A
kinase domain of the mycobacterial CoaE was cloned from the M.
tuberculosis genomic DNA using the primers CoaE_Fwd:59-
GGAATTCCATATGGTGACCGACCGCGAT–39and NTD-
Rev: 59-CCCAAGCTTTTAGGGCTGGACGCGCGTGTTC-
CAGACG-39 designed to ligate in the NdeI/HindIII sites of
pET 28a+ expression vector to obtain a hexa-histidine-tagged
recombinant protein which was expressed in E. coli BL21 (DE3)
cells. When conditions similar to those used for the expression and
purification of the full-length enzyme did not yield soluble NTD,
variations in temperature post induction, concentration of IPTG
for induction and total culture volume were implemented. Though
soluble expression of the His-tagged NTD increased very slightly
using 12-litre cultures, the now-relatively-soluble hexahistidine
tagged protein did not bind to the Ni-NTA column possibly due to
an altered pattern of folding in the absence of the CTD, which
possibly caused the hexa-histidine tag to get buried and therefore
unavailable for binding to the column. We then resorted to
classical protein purification methods like urea denaturation and
ammonium sulphate precipitation to increase yield but none of the
methods yielded sufficient quantities of soluble protein [23]. The
NTD was then cloned in the pETGEXCT vector and this GST-
tagged protein was then loaded on a Glutathione-Agarose column
and eluted using reduced glutathione.
Cloning, Expression, and Purification of the C-terminal
Domain and Its Various Deletes
The 211-amino acid long UPF0157 domain of the mycobac-
terial CoaE was cloned in the pET28a+ vector in the NdeI/
HindIII sites using the primers CTD-For: 59-GGAATTCCA-
TATGGCGCACAA-39 and CoaE_Rev: 59-CCCAAGCTTT-
TAACGCAAATGCAC-39. Primer sequences for all the CTD
deletes are as mentioned in Table S1. These histidine-tagged
proteins were expressed and purified using conditions similar to
those used for the full-length enzyme.
Results
A BLAST analysis of the putative tubercular dephosphocoen-
zyme A kinase, Rv1631, reveals that the mycobacterial enzyme is a
two-domain protein, with the 196-residue N-terminal domain
(NTD) encoding the dephosphocoenzyme A kinase and a 211-
residue C-terminal domain (CTD) belonging to the UPF0157
family of Proteins of Unknown Function also known as GrpB
(Glutamate rich protein B) (Fig. 1A). The Pfam database for this
family, UPF0157, shows that it is present in 174 species across all
kingdoms of life, ranging from archaea, cyanobacteria, viruses,
S. cerevisiae, C. elegans, the nematodes, fruit flies, mice and even
humans, in 5 different domain architectures and in 244 different
sequences (Fig. 2A and B). Computational analysis of Rv1631, a
1224 bp gene, showed that it does not cluster with the genes for the
other enzymes of the CoA biosynthesis pathway on the mycobac-
terial genome. Most of the genes in the region of the genome around
the coaE gene (1825.6 Kb to 1845.6 Kb) either code for conserved
hypothetical proteins or those for which only putative functions are
known till date. We cloned the mycobacterial CoaE gene in the
pET28a+ vector and expressed it in E. coli BL21 (DE3) cells. The
recombinant protein was purified by immobilized metal affinity
chromatography (Fig. 1B). The expression of the hexahistidine-
tagged, 47 kDa recombinant mycobacterial CoaE was further
confirmed by Western blotting with anti-His antibodies (Fig. 1C).
Characterization of CoaE
CoaE phosphorylates DCoA using ATP as the phosphate donor,
generating CoA and ADP. Enzymatic activity was assayed using two
different coupled assays, the pyruvate kinase/lactate dehydrogenase
system (Fig. 3A) that assays for ADP formation and the a-
ketoglutarate dehydrogenase single coupled system (Fig. 3B) that
assays for CoA formation. The reaction system using c-labeled ATP
further confirmed that the hexahistidine tagged, mycobacterial CoaE,
was an active protein (Fig. 3C). Using the coupled assays, the Km and
Kcat values for ATP were found to be 56.8 mM and 2.86 min21
while those for DCoA were determined as 34.9 mM and 1.75 min21.
Both substrates behaved as Michaelis-Menten substrates over the
range of concentrations studied. Km values have only been reported
from two prokaryotic sources till date, the E. coli enzyme (740 mM for
ATP and 140 mM for DCoA) and the Corynebacterium ammoniagenes
enzyme (120 mM for DCoA) [16,24]. Comparison with these values
shows that the mycobacterial enzyme has a higher affinity for both its
substrates. Moreover, the mycobacterial CoaE is catalytically 21
times more proficient (Kcat/Km 0.0503 mM21 min21) as compared
to its E. coli counterpart.
Enzyme Assay by Isothermal Titration Calorimetry
In order to rule out the over-estimation of kinetic constants by
the coupled assays, we also adopted a more direct, thermodynamic
Table 2. Types of contacts made by the modeled mycobacterial CoaE with its substrate, Dephosphocoenzyme A, its product
Coenzyme A and the metabolic regulator, CTP, as calculated by the LPC/CSU software [22].
Types of Contacts Dephosphocoenzyme A Coenzyme A CTP
Hydrogen bonds 26 24 28
Hydrophobic 20 19 13
Aromatic-Aromatic 4 - 2
Acceptor-Acceptor 2 3 1
Other 37 51 41
doi:10.1371/journal.pone.0007645.t002
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Table 3. Analysis of the docked ligands.
Dephosphocoenzyme A Coenzyme A CTP
Complex Surf(A2) 453.1 529.8 88.9
Uncomplex Surf(A2) 890.1 996.7 612
Interact. Residue Dist(A˚) Surf(A˚2) No. of contacts Dist(A˚) Surf(A˚2) No. of contacts Dist(A˚) Surf(A˚2) No. of contacts
GLY 9 - - - 3.8 4.9 3 - - -
ILE 10 5 25 6 4.3 22.6 10 - - -
GLY 11 - - - 3.7 42.6 5 - - -
ALA 12 - - - 4.6 0.2 1 - - -
GLY 13 - - - 3.8 3.1 2 - - -
LYS 14 - - - 3.4 58.4 11 - - -
SER 15 - - - 3.8 29.1 7 - - -
LEU 16 - - - 4.6 9.2 2 - - -
GLY 31 5 2.7 2 - - - - - -
ASP 32 2.4 50.4 15 5.4 2.9 1 2.4 49.9 4
ALA 35 3.9 27.6 5 - - - 3.4 14.3 2
ARG 36 2.9 32.8 9 2.6 64.6 12 3.3 24.6 10
VAL 39 3.6 15.4 1 3.6 15.4 1
GLN 40 - - - 6 5.4 2 - - -
LEU 58 - - - 5.8 0.6 1 - - -
LEU 64 - - - 5.3 7.6 2 - - -
ASP 65 - - -9 3.6 28.9 7 - - -
ARG 66 2.5 126.5 16 2.5 116.1 21 3 60.2 13
GLN 67 3.4 33.2 7 3.8 46 15 - - -
LEU 69 - - - - - - 3.2 22.3 5
ALA 70 - - - - - - 4.4 5.4 2
ALA 73 - - - - - - 3.6 42.1 6
PHE 74 - - - - - - 3.8 47.3 9
ARG 80 - - - - - - 2.7 63.4 10
LEU 83 - - - - - - 3.3 14.3 4
ASN 84 - - - - - - 3.9 44.9 8
VAL 87 4.6 17 3 - - - 3.6 30.2 8
HIS 88 3.7 28.2 14 - - - 5 12 10
VAL 91 5 4.9 1 - - - - - -
ARG 95 6.2 0.4 1 - - - - - -
ILE 112 3.8 50.4 16 - - - 3.7 17.7 1
PRO 113 4 9.4 2 - - - - - -
VAL 116 - - - - - - 4.7 0.7 1
GLU 117 2.6 42 4 - - - 2.2 44.5 5
ARG 153 5.3 5 2 - - - - - -
ALA 154 5.6 6.6 2 - - - - - -
ALA 157 3.9 28.6 7 - - - 2.4 46.8 8
ALA 158 3.5 25.3 2 - - - 4 11.3 1
ARG 140 - - - 3.8 56.6 12 - - -
GLN 144 - - - 4.8 4.7 3 - - -
The first two lines show the solvent-accessible surface area (A˚2) of the ligands (the enzyme’s substrate, dephosphocoenzyme A; its product, coenzyme A and its
metabolic regulator, CTP) in complex with the protein and in their uncomplexed forms. Then follows a detailed comparative analysis of the residues in the
mycobacterial CoaE interacting with the ligands, showing the distance between the interacting residue and the ligand in A˚, the surface area of contact in A˚2 and the
number of contacts formed by an individual amino acid residue with the ligand.
doi:10.1371/journal.pone.0007645.t003
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approach to calculate the same. The Km and Kcat values
calculated by ITC correlate well with those calculated by the
single- and double-coupled assays (Fig. 3D–F). The negative
deflections in the binding thermograms show that the reactions are
exothermic (Fig. 4A, C and E). Taken together, these data reveal
that the mycobacterial CoaE indeed has a higher affinity for both
its substrates and a considerably greater value of Kcat (21 times)
compared to its counterparts in other prokaryotes.
Substrate Binding Studies
CoaEs belong to the P-loop containing nucleotide triphos-
phate hydrolase superfamily. Our ITC studies on the myco-
Figure 1. Mycobacterial CoaE domain organization and protein expression. A, The mycobacterial CoaE has a 196 amino acid (a.a.) N-
terminal dephosphocoenzyme A kinase and a 211 a.a. C-terminal domain of unknown function, the UPF0157. B, elution profile of hexahistidine
tagged mycobacterial CoaE purified by affinity chromatography as collected fractions loaded on a 12% SDS-PAGE, M, protein molecular weight
marker; P, cell pellet obtained post sonication and centrifugation; L, supernatant obtained post centrifugation of the sonicate, loaded onto the
column; FT, Flow through from the column upon loading the supernatant; Wash, Fractions collected during column washing with resuspension
buffer; Elution, the elution profile represented by fractions collected during elution with buffer containing 100 mM imidazole. C, confirmation of the
clone by Western blotting using anti-Histidine antibodies against the recombinant His-tagged CoaE (Lane 3) and His-tagged Plasmodium falciparum
FabI as a positive control (Lane2). Lane 1 carries the pre-stained molecular weight marker.
doi:10.1371/journal.pone.0007645.g001
Mycobacterial CoaE
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bacterial CoaE reveal as yet unknown features for this class of
enzymes. The two substrates, DCoA and ATP, are presumably
located in separate and well defined binding pockets of the
enzyme, as is seen in all the other enzymes belonging to this
superfamily of P-loop containing proteins. The ternary complex
between the enzyme and its substrates may either be formed via
an obligatory sequential pathway or by a random mechanism of
substrate addition. Sequential addition of substrates can follow
either of the following two routes: CoaE R CoaE?DCoA R
CoaE?DCoA?ATP (reactions i and ii of Scheme 1) or CoaE R
CoaE?ATP R CoaE?ATP?DCoA (reactions iii and iv depicted
in scheme 1). On the other hand, if substrate binding follows
a random mechanism, binding of one substrate to the enzyme
would not be a prerequisite for binding of the other, and
all four reactions of Scheme 1 can take place with equal
probability.
CoaE {i?CoaE:DCoA
iii; ;ii
CoaE:ATP {iv?CoaE:DCoA:ATP
Scheme 1. Formation of the ternary enzyme-substrate
complex, CoaE?DCoA?ATP. If the reaction follows an ordered
sequential pathway, it may take the routes i and ii OR iii and iv. If,
on the other hand, the substrates bind in a random fashion, all
four reactions have an equal probability of occurrence.
To explore the mechanism of formation of the ternary complex,
i.e. the order of substrate binding, two sets of experiments were
designed. In the first set, DCoA binding to the enzyme was
studied, while in the second set, CoaE was first saturated with
ATPcS and then DCoA was added as the binding ligand. Fig. 4
Figure 2. The C-terminal Domain of the mycobacterial CoaE belongs to the UPF0157 family. A, Taxonomic distribution of the UPF0157
proteins. B, The unique domain organizations/architectures in which the UPF0157 domain is found. (i) 201 sequences with the architecture: UPF0157
(ii) 25 sequences with the architecture: CoaE-UPF0157 (iii) 10 sequences with the architecture: Acetyltransferase(ACT)-UPF0157. (iv) 7 sequences with
the architecture: UPF0157-Acetyltransferase (ACT) (v) one sequence with the architecture: UPF0157-cytidine and deoxycytidylate deaminase
(dCMP_deam) zinc-binding region.
doi:10.1371/journal.pone.0007645.g002
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Figure 3. Biochemical characterization. Coupled assay systems used to determine CoaE activity. A, The double-coupled assay system using
Pyruvate Kinase (PK) and Lactate Dehyrdrogenase (LDH) which assays for ADP formation. B, The single-coupled assay system using a–ketoglutarate
dehydrgenase (a-KDH) which assays for CoA formation. C, Radioassay employing cP32-ATP as a substrate for CoaE. TLC shows the separation of the
products of the reaction mixture containing DCoA (0.25 mM), ATP (0.25 mM), cP32-ATP (0.5 uCi), MgCl2 (10 mM), DTT (1.5 mM) in 50 mM Tris, pH 8.0,
on a Whatman 3 MM paper in a developing system containing isobutyric acid:0.5 N ammonium hydroxide (100:60) and 1 mM EDTA confirmed that
the recombinant CoaE was an active enzyme. D, Enzyme kinetics with varying [DCoA]. E, Enzyme kinetics with varying [ATP]. 1.4 mL of 1 uM CoaE
(dialyzed 12–18 hrs in 25 mM Tris buffer, pH 7.8, 150 mM NaCl, 10 mM MgCl2, 20 mM KCl, 5% glycerol) was preincubated with 1 mM DCoA for
30 mins and was titrated against 1 mM NH-ATP (298 uL) at 20uC. Raw data were collected for substrate heats of dilution in the buffer and integrated
using the Microcal Origin 7.0 software. F, Kinetic parameters determined for the substrates of the mycobacterial CoaE, ATP and DCoA.
doi:10.1371/journal.pone.0007645.g003
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Figure 4. Representative ITC measurements. A and B, titration of 1 mM DCoA against 200 uM CoaE, C and D, titration of 1 mM DCoA against
1 mM ATP-saturated CoaE, E and F, titration of 1 mM ATP against 200 uM CoaE, G and H, titration of 1 mM ATP against 1 mM DCoA-saturated CoaE.
Raw data are shown as differential power signals in A, C, E, and G. In B, D, F, and H, the area under the curve produced on each injection was
integrated (filled squares) and was plotted against the molar ratio of DCoA to enzyme binding sites using the Origin 7.0 software. The solid lines
represent nonlinear best fits for a single-site binding model. Titrations were performed in 50 mM Tris/HCl, 150 mM NaCl, 5% Glycerol, pH 7.8 at 20uC.
doi:10.1371/journal.pone.0007645.g004
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shows the representative titrations of DCoA against CoaE alone (A
and B) and ATPcS-saturated CoaE (C and D). The mean values of
the thermodynamic parameters at 20uC and pH 7.8 for the
titration of DCoA against substrate-free enzyme, resulting from
five independent measurements, are KB = 1.43610
24 M21 and
DHbind =23719 cal mol
21 (Table 1). As can be seen from
Fig. 4A,B and B,C there was no significant difference in DCoA
binding to the enzyme in the presence or absence of ATPcS and
similar values of change in enthalpy and binding constant were
obtained. On the other hand, ATP (or ATPcS), by itself, did not
bind to CoaE (Table 1, Fig. 4E and G). Interestingly, when ATPcS
was titrated against DCoA-saturated CoaE, a good binding
isotherm was observed, with KB and DHbind values obtained from
five independent measurements, as 2.0661024 M21 and
23776 cal mol21 respectively. Thus our experiments illustrate
that CoaE follows a sequential mechanism of substrate addition
with DCoA as the leading substrate and ATP following in tow.
While the reaction product, ADP has a moderate affinity with KB
and DHbind values of 2.03610
24 M21 and 23612 cal mol21
respectively, the product, CoA fails to bind to the enzyme
irrespective of the presence or absence of ADP (Fig. 5B). Thus the
CoaE reaction occurs mostly in the forward direction.
Phosphate Donor Specificity of CoaE
We also determined the phosphate donor specificity of CoaE
using various NTPs and dNTPs as donors. Both the assay systems
gave consistent results. GTP, CTP, ADP, dATP, dGTP were used
as phosphate donors and both, kinetics as well as binding energetics,
were elucidated for each of them. dATP was weaker as a phosphate
donor compared to ATP (Fig. 6A) and exhibited a Km of 320 uM
(Fig. 6D). In contrast, dGTP and GTP were incapable of donating
a phosphate group both in the presence and absence of DCoA and
neither bound the enzyme well. The data for GTP as a
representative of these is shown in Fig. 6B. Interestingly, CTP was
inactive in phosphorylating DCoA but it bound CoaE well
exhibiting a binding constant of 1.5961024 M21(Fig. 6C) in the
absence of DCoA. In contrast, CTP fails to bind to the CoaE-DCoA
complex.
Influence of CTP on CoaE
Following up on the lead of strong binding, but a lack of DCoA-
phosphorylating activity of CTP, the latter’s effect on CoaE activity
and catalysis was further examined. The enzymatic reaction was
inhibited upon preincubation with CTP, exhibiting a Vmax of
0.89 uM min21, compared to a Vmax of 1.75 uM min21 in the
absence of CTP. On the other hand, CTP did not inhibit the
reaction upon addition to a DCoA-saturated CoaE reaction.
Homology Modeling of the Mycobacterial CoaE
Extensive computational analyses on the full length mycobacte-
rial CoaE and its individual domains was carried out (Supporting
Information File S1, Table S2).The mycobacterial enzyme was
homology modeled and this structure was then validated extensively
(Supporting Information File S1, Fig. S3). We subjected our
modeled, energy-minimized NTD-CoaE structure to a structural
homology search by the DALI server which generated 27 proteins
with strong structural similarity (Z score .7) to the mycobacterial
CoaE. All these proteins are actually structural neighbors of CoaE
in the P-loop containing NTP hydrolases superfamily under SCOP
[25]. Remarkably, a majority of very close structural homologs to
the mycobacterial CoaE are the uridylmonophosphate/cytidylmo-
nophosphate kinases, deoxycytidine kinases and the cytidylate
kinases from several different sources, with RMSD values in the
range of 2.8–3 A˚ and Z-scores in the ranges of 8.8–11.6 for more
than an average of 148 in 194 residues. This is interesting in the light
of the fact that CTP inhibits mycobacterial CoaE activity and a
DALI search also picks CTP-binding proteins as close structural
homologs, further lending credence to the strong binding shown by
CTP to the enzyme and its role in enzyme regulation.
Ligand Docking Analyses
We carried out a detailed comparative analysis of the residues in
the mycobacterial CoaE interacting with the ligands, the enzyme’s
substrate, DCoA; its product, CoA and its metabolic regulator,
CTP, calculating the distance between the interacting amino acid
residues and the ligand (A˚), the surface area of contact (A˚2) and the
number of contacts formed by an individual residue with the
ligand (Tables 2 and 3, Supporting Information File S1). DCoA
Figure 5. Feedback inhibition by the reaction products. A, 1 mM
ADP titration against 200 uM CoaE. B, a representative isotherm of
1 mM CoA titration against 200 uM CoaE.
doi:10.1371/journal.pone.0007645.g005
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was docked onto the modeled CoaE and it fit snugly in the deep
cleft between the core and CoA domains similar to the putative
DCoA-binding site for the Haemophilus enzyme proposed by
Obmolova et al. [26], the interaction being stabilized by 26
hydrogen bonds and 20 hydrophobic interactions (Table 2). DCoA
bound the enzyme in such a way that its adenine base was in a
Figure 6. Phosphate donor specificity analysis. Binding and kinetic reactions were carried out with alternate phosphate donors. A, B and C,
Representative binding isotherms for 1 mM dATP, 1 mM GTP and 1 mM CTP binding to 1 mM DCoA-saturated 200 uM CoaE respectively. D, Kinetics
with 1 mM dATP. In A, B and C, the lower plot shows the integrated area under the binding curve, per experimental point.
doi:10.1371/journal.pone.0007645.g006
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hydrophobic environment provided by Ala35, Val87, Val91,
Ile112, Leu114, Leu115, Ala157 and Ala158 (Fig. 7A) all of which
are conserved residues. Glu117 and His88 make strong hydrogen
bonds with the adenine base of the DCoA molecule in
hydrophobic contact with the side chains of Val 91, Ile 112.
DXD Motif
In this orientation, the 39 OH group of the ribose is poised for
interaction with the catalytic Asp32, the carboxyl group of which is
within hydrogen bonding distance. The conserved Asp32 supports
the coordination of Mg2+ and is the general base that fuels
nucleophile activation for an attack on the ATP c-phosphate.
Interestingly, we observed that the catalytic aspartate exists in the
sequence in tandem with another aspartate residue forming a
DXD motif (where X can be any amino acid), in almost all of the
dephosphocoenzyme A kinases, ranging from the extremophiles
Thermus thermophilus, Dienococcus radiodurans; root-nodule forming
Rhizobium; pathogens mycobacteria, corynebacteria; symbiotic
lactobacilli; the worm, C. elegans, yeasts, plants and even the
mammalian enzymes. A few members of the P-loop containing
superfamily ranging from gluconate kinases, shikimate kinases,
thymidylate kinases, APS kinases also possess this motif. The
carboxylate group of Asp 30 is close to that of Asp32 and could in
all probability be increasing the pKa of the catalytic aspartate
priming it further for nucleophile activation, allowing it to function
as a stronger base, as is the case in the E. coli RecA protein, an
ATPase, where an aspartate residue at 4.2 A˚ distance from the
catalytic glutamate increases the latter’s pKa and therefore primes
it for faster catalysis [27]. This aspartate residue may also be
involved in coordinating the Mg2+ ion as in shikimate and
gluconate kinases [28,29]. Like in most kinases, Arg36, Arg66,
Arg140 and Gln144 help stabilize the phosphate groups of the
DCoA molecule. Pro113 which is a critical residue involved in
forming the hydrophobic pocket for DCoA binding and is strictly
conserved among all CoaEs from prokaryotic sources is replaced
by an alanine residue at the corresponding position in the
mammalian bifunctional enzymes (Fig. 7A).
CTP Docking Analyses
ATP failed to dock close to the P-loop which is not surprising in
light of our binding studies which suggest that ATP does not bind
to the enzyme in the absence of DCoA. Interestingly, CTP does
not dock at the P-loop (Fig. 7B). While docked at a unique site,
CTP shows a tight binding interaction with the enzyme, the
association being stabilized by 28 hydrogen-bonded interactions
and 12 hydrophobic interactions (Table 2). Basic residues, Arg80
and Asn 84 are involved in stabilizing the negative charges of the
phosphates. The phosphate oxygens form several contacts with the
backbone amino groups. The cytosine base is in the hydrophobic
pocket formed by residues Ala35, Ala36, Ile112, Val87 and Val39.
Leu69 is also involved in hydrogen-bonding interactions with the
sugar while Ala73, Leu83, Val87, highly conserved residues,
provide a hydrophobic environment to the ribose (Fig. 7B). The
59-methylene group is in Van der Waals contact with Phe74.
Similar residues were found to interact with CTP in the E. coli
CoaB structure [30]. Arg66, which is completely conserved in the
entire family, forms strong hydrogen bonds with the base and the
ribose sugar. Interestingly, this residue is involved in stabilizing the
phosphates in the DCoA molecule. A majority of these residues
which interact with CTP in our docking analysis are a part of the
DCoA binding site. It’s binding to a site extraneous to the P-loop
explains CTP’s incapacity to donate a phosphoryl group despite its
strong binding to the enzyme. The strong interaction shown by
CTP with the residues involved in binding and stabilizing DCoA,
also explains how CTP is capable of inhibiting enzyme catalysis.
The Role of the Domain of Unknown Function, UPF0157,
in Mycobacterial CoaE
In order to determine whether the mycobacterial CoaE NTD is
capable of independent expression and catalysis as the full length
enzyme, in the absence of the UPF0157 domain at its C-terminus,
the NTD and CTD (the UPF0157 domain) were individually
cloned in the pET28a+ vector. On expression in E. coli BL21
(DE3) competent cells, a majority (90–98%) of the hexahistidine
tagged NTD protein went into the insoluble fraction. In contrast, a
major fraction of the CTD alone was expressed in the soluble
form. All attempts to express the NTD alone in its soluble form,
even by modification of the conditions of its induction were to no
avail. Also, attempts to purify the His-tagged NTD, in the absence
of the CTD, from the insoluble fraction were not fruitful.
Interestingly, only when it was expressed in fusion with
Glutathione-S-Transferase (GST) at its C-terminus (using the
pETGEXCT vector which allows the production of C-terminal
fusions of GST), NTD with full retention of its enzyme activity was
found to be completely (95%) in the soluble fraction. In contrast,
neither did an N-terminal fusion of GST to the NTD nor the
expression of GST in trans to the NTD (on a separate plasmid co-
transformed with the NTD-pET plasmid) yield any protein in the
soluble fraction. The full length protein that contains both the
NTD and the CTD is found completely in the soluble form with
full activity. The NTD alone, on the other hand, cannot be
expressed without the CTD (or GST at its C-terminus). The CTD,
however, fails to assist the folding of other proteins and therefore
in all probability, does not act as a general chaperone in the cell
(Supporting Information File S1, Fig. S1). Thus the UPF0157
domain, i.e. the mycobacterial CTD, serves a specific role in the
proper folding of the NTD as evident from its appearance in
soluble form with full retention of its activity.
We next determined whether deleting a part of the CTD affects
the expression of CoaE in the soluble form with a retention of its
full enzymatic activity. Initially, we constructed deletes of 10, 20,
30, 40 and 50 amino acids from the C-terminus of the CTD, none
of which affected full-length protein expression or activity.
Focusing then on the N-terminus of the CTD, 150, 100 and 50
residues were deleted from this end of the CTD. Despite all
attempts, none of these yielded protein in the soluble fraction. To
further delineate the exact region in the CTD that is involved in
the specific NTD-chaperoning activity, we deleted 14 and 35
residues from the beginning of the CTD, both of which expressed
soluble protein. Characterization of the CTD-ND35 mutant
revealed that it has a Kcat/Km value of 0.0362 mM21 min21,
which is approx. 72% of the wtCoaE that contains both the NTD
and the full length CTD. The mycobacterial dephosphocoenzyme
A kinase therefore requires a specific unit on its C-terminus which
facilitates its folding, maturation and functional expression. This
role was performed by GST in the NTD-GST clone and is carried
out by residues 35–50 (KIACGHKALRVDHIG) of the UPF0157
domain in the full length enzyme.
Other probable functions of the UPF0157 domain were
investigated but each was ruled out (Supporting Information File
S1). A possible cis-regulatory role of the CTD, in terms of the full
length enzyme, by affecting catalysis by the NTD upon binding
the substrates and products of the kinase was ruled out. The N-
terminal 200 residues of the human bifunctional CoaDE, were
recently shown to target the human enzyme to the mitochondrial
outer membrane and effect activation of both the enzymatic
domains by membrane phospholipids [12]. We explored the
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Figure 7. Docking studies. The protein residues have been drawn as green ball-and-stick models and the ligands in cyan. The figures were
generated using PyMol. A, Schematic depicting the residues in the mycobacterial CoaE interacting with DCoA and the docked ligand. The encircled
residues are the ones which interact with the leading substrate and differ from those of the host enzyme. B, Schematic depicting the residues in the
mycobacterial CoaE interacting with CTP and the docked ligand.
doi:10.1371/journal.pone.0007645.g007
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possibility of a similar activation of the mycobacterial CoaE,
effected in this case by the UPF0157 domain at the C-terminus,
using radiolabeled ATP and phospholipid vesicles, prepared in the
laboratory, but no significant enhancement of CoaE activity was
seen (Supporting Information File S1, Fig. S2). The mycobacterial
CTD shows a faint homology to S-adenosyl methionine (SAM)-
dependent methyltransferases in a PSI-BLAST search. All
attempts to assign such an activity to UPF0157 by a methyltrans-
ferase assay, using SAM as the donor, were unsuccessful. Also, lack
of heat exchange when the full length CoaE was titrated against
SAM under a variety of conditions ruled out such a role. We
further explored the possibility of the CTD channeling the
49-phosphopantetheine (49-PP) moiety from CoA as soon as it is
synthesized by the mycobacterial CoaE, but the cloned UPF0157
domain did not show any phosphopantetheinyl transferase activity
(Supporting Information File S1).
Discussion
CoaE catalyses phosphoryl transfer in the last step of CoA
biosynthesis and has been shown as an essential enzyme. The
differences between eukaryotic and prokaryotic CoaE proteins,
prompted us to characterize the kinetic mechanism of CoaE from
the human pathogen M. tuberculosis. Its indispensable role renders it
an attractive target for the development of anti-mycobacterial
agents. The mechanism of the forward reaction was explored and
elucidated using steady-state kinetics by coupled enzyme-spectro-
photometric assays and ITC. The Km values of 34.9 mM for
DCoA and 56.8 mM for ATP are the lowest, compared to those
reported for this class of enzymes from bacteria. The CoaE
domain of the human bifunctional CoA synthase shows a very low
Km of 5.2 mM for DCoA and this high affinity of the human
bifunctional enzyme for DCoA may be attributed to the merger of
the CoaD and CoaE activities, which possibly helps channel the
DCoA product of CoaD faster to the CoaE active site, therefore
resulting in a catalytically more efficient bifunctional enzyme [5].
This study reports, for the first time, that CoaE has a sequential
ordered mechanism of substrate binding with DCoA being the
leading substrate and ATP following in tow as ATP binding to the
enzyme is not as efficient as that when the enzyme is a priori
saturated with DCoA while DCoA binding is unaffected by the
presence or absence of ATP. A more positive change in entropy
(15.9 cal M21 K21) is seen for DCoA binding than that seen with
ATP (6.85 cal M21 K21). This indicates that DCoA binding
facilitates ATP binding by inducing conformational changes in the
enzyme and preparing the ATP-binding pocket for a snug fit.
Of all the phosphate donors evaluated for the mycobacterial
enzyme, dATP binds reasonably well to CoaE with a binding
constant of 1.7461024 M21, though it is poor in phosphoryl
transfer. In contrast, GTP and dGTP fail to bind to CoaE. ADP
being structurally quite similar to ATP is capable of fitting in the
ATP-binding pocket but is catalytically inactive, proving the
substrate specificity of CoaE for ATP. A reduction in the catalytic
efficiency with ADP can also possibly be because the nucleophiles
on DCoA, which attack the ATP c-phosphate, are in closer
proximity to ATP than ADP and thus the phosphoryl transfer is
more efficient in the presence of ATP, besides the intrinsic lability
of the high energy b2c phosphoryl bond.
ADP’s strong binding to CoaE prompted us to study the reverse
reaction, i.e. the conversion of CoA and ADP to DCoA and ATP,
which we observed was extremely slow and in all probability,
negligible in the cell. This was lent further credence by the fact
that CoA binds extremely poorly to CoaE. Also, considering the
fact that CoaE synthesizes a critical cell metabolite, it is safe to
conclude that a majority of the reaction goes on in the forward
direction to constantly replenish the ever-depleting CoA pool in
the cell. CoA is known to feedback regulate its biosynthesis by
acting on the first committed step of the pathway, catalyzed by
pantothenate kinase and inhibiting the reaction [31]. The non-
binding of CoA to CoaE also shows that CoA is incapable of
directly feedback regulating its own production at the last step of
the biosynthetic pathway.
Being structurally distant to ATP due to the pyrimidine ring,
CTP’s stronger binding to CoaE relative to GTP, which possesses a
purine ring as ATP, came as a surprise. This raised an interesting
question about the possible role of CTP in regulation of CoaE. Such
a role is not uncommon in the biological context as several enzymes
are regulated by NTPs other than their respective natural substrates.
Therefore, we decided to further explore the relevance of its strong
interaction with the mycobacterial enzyme. While CTP did not
participate in phosphoryl transfer, preincubating the enzyme with
CTP inhibited the enzyme. Conversely, CTP bound the enzyme
poorly when the latter was preincubated with DCoA alone before
the addition of CTP. Docking CTP on CoaE reveals that the there is
an overlap in the binding pocket utilized by CTP and DCoA which
renders an explanation for the inhibition shown by CTP. A
regulatory mechanism is seen emerging from these studies whereby
CTP limits the catalytic efficiency of CoaE when it binds the enzyme
before the enzyme interacts with its leading substrate.
Regulation of enzyme activity by CTP is slightly unlikely in an
everyday-context considering the fact that ATP is the major
phosphoryl donor in the cell and is vastly abundant relative to
CTP in the cellular context. The cell has possibly devised this
unique mode of regulation of this critical biosynthetic enzyme to
prepare itself for circumstances when ATP levels drop precip-
itously. Therefore, in the physiological context, this regulation
might have consequence in the face of adversity, when the cell
needs to minimize metabolite flow through a majority of its
pathways and maintain a basal level of metabolism. Also, it has
been well documented that in facultative anaerobes, like
mycobacteria, the cellular CoA pools vary greatly in response to
various stresses [32–34]. Therefore, under circumstances where
the cellular ATP/CTP ratio becomes low, CTP is recruited which
helps in fine-tuning the levels of the cellular CoA pool by
modulating its activity, to limit the biosynthesis of CoA. Thus
CTP might help in regulating CoA biosynthesis under stress
conditions therefore helping the organism tide over harsh
conditions. In view of the evidence presented here, the currently
held view of the regulation of the CoA pathway only at its first step
needs to be reconsidered with a greater role allocated to CoaE
than previously assigned. Considering the ever-changing environ-
ment this robust organism faces in the host, with a regular
onslaught of drugs and the need to constantly fine tune its
metabolism according to the surrounding conditions, regulation
effected by CTP may be an effective system to bring about rapid
changes in the cellular CoA levels.
We further validated our results by modeling the mycobacterial
CoaE and studying its interactions with its substrates, DCoA and
ATP; its product, CoA and the intrinsic metabolic regulator, CTP.
Docking studies show a snug fit for DCoA in the acceptor substrate
binding site, well poised for a nucleophilic attack on the ATP
c-phosphate, its interaction being stabilized by a total of 89
contacts (Table 2). Docking also revealed residues interacting with
the leading substrate in the pathogen’s enzyme which are different
from the ones in the human enzyme (Fig. 7B). These can therefore
be exploited for developing inhibitors against the enzyme. Our
docking analyses also explain the inability of CTP to serve as a
phosphoryl donor to DCoA as it shows specific and stoichiometric
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binding at a site distinct from that of ATP (the P-loop). These
results also unequivocally explain the kinetic inhibition shown by
CTP by virtue of its binding at the same site as DCoA and
therefore obscuring the acceptor substrate binding site.
The mycobacterial enzyme has two domains as revealed by
BLAST analysis, a 196-residue NTD homologous to known
dephosphocoenzyme A kinases and a 211-residue CTD belonging
to a family of proteins of unknown function (UPF0157). When
attempts to purify the NTD alone were not fruitful, it appeared
imperative to rethink the strategy being employed. Considering
the fact that the mycobacterial genome has undergone a
considerable amount of downsizing with a concomitant loss of
redundant genes, there has to be a rationale for the organism
carrying the supposed ‘burden’ of a domain of no function, the
CTD of the mycobacterial CoaE. We probed a possible role of the
UPF0157 domain in assisting the NTD in folding as a separately
cloned NTD alone was incapable of independent, soluble
expression. Such a function is not uncommon in the biological
context and has been observed in several multidomain proteins, an
example being the human CoaDE bifunctional enzyme complex
which possesses a third domain apart from the two enzymatic
domains. This 200-residue N-terminal domain in the human
enzyme complex is absolutely required for the proper expression
and folding of the protein when overexpressed in E. coli. Thus, the
CTD of the mycobacterial CoaE might also act in a similar fashion
and thereby assist the NTD in attaining its biologically functional
conformation. If the CTD performs such a function, replacing it
with a protein of similar function should aid NTD solubilization to
some extent. Indeed, consistent with this hypothesis, expression of
the NTD in fusion with glutathione-S-transferase at its C-terminus
led to the expression of a soluble NTD that showed 95% activity of
the full length protein while an N-terminal GST fusion did not
yield soluble protein. Co-transformation of GST and the NTD on
separate plasmids also did not facilitate NTD folding, ruling out a
possible chaperonic effect in trans. Further investigations using a
series of deletion mutants revealed that the stretch of amino acids
from 35–50 of the UPF0157 domain are indispensable for the
proper soluble expression and appropriate folding of a completely
soluble and active NTD. The CTD, therefore, might not act as a
universal chaperone in the cell but it specifically helps the
mycobacterial CoaE NTD domain attain a properly folded
structure. Thus, of all putative roles that we have examined for
the UPF0157 domain at the C-terminus of mycobacterial CoaE,
the only physiologically significant role to emerge is its ability to
facilitate the expression of the NTD in a folded/catalytically
competent form. Such a role could also be possible in cases where
this domain is found either upstream or downstream of an
acetyltransferase.
In summary, our results establish a new paradigm for depho-
sphocoenzyme A kinases providing a framework for understanding
how this class of enzymes interact with their substrates. From this
work a regulatory model for the CoA pathway emerges which
provides insights, into the probable mechanisms employed by the
cell, to keep the metabolite flow at this until now-underexplored,
though critical step in the CoA biosynthesis under check. These
studies show that the end product of CoA biosynthesis, CoA,
cannot feedback regulate its own production at the last step of the
pathway, but the cell utilizes other subtle means to regulate
metabolite flow, using an intrinsic metabolic inhibitor, CTP,
which by virtue of its binding at a site, distinct from that of ATP, is
unable to act as a phosphate donor but can easily inhibit the
enzyme due to its binding at a site overlapping that of the acceptor
substrate, DCoA as illustrated by homology modeling and docking
studies. Therefore, under conditions of metabolite paucity and
stress, the cell calls upon CTP to monitor the flow at the CoaE
step. In view of the evidence presented in this work, the widely
understood mechanism of regulation of Coenzyme A biosynthesis;
which considers feedback regulation by CoA at the pantothenate
kinase step of the pathway to be the sole means of metabolite flow
regulation of this critical biosynthetic pathway, needs to be revised
and a broader role for the last enzyme in the pathway, CoaE,
needs to be considered. We have also for the first time,
experimentally established a role for the UPF0157 domain from
the Pfam database in acting as a very specific chaperone.
Supporting Information
Supporting Information File S1
Found at: doi:10.1371/journal.pone.0007645.s001 (0.04 MB
DOC)
Figure S1 Universal Chaperone Assays for the CTD. In order to
determine whether the CTD has a general chaperonic role in the
cell, DTT-induced insulin aggregation assays were carried out
with the CTD and CoaE as chaperones. The assay mixture with
insulin (0.6 mg/mL), DTT (30 mM) was carried out in 50 mM
phosphate buffer, pH 7.4 at 37uC. Varying concentrations of the
CTD and CoaE were used for protection.
Found at: doi:10.1371/journal.pone.0007645.s002 (4.35 MB TIF)
Figure S2 Activation of CoaE activity by phospholipids effected
by the CTD. CoaE activity was assayed using 0.2 mM DCoA,
0.25 mM ATP, 0.5 uCi cP32-ATP, 1.5 mM DTT, 10 mM
MgCl2, 150 mM Tris, pH 8.0 and varying concentrations of
phospholipids vessicles (X = 10 Mm) by the assay system used in
Fig. 3C.
Found at: doi:10.1371/journal.pone.0007645.s003 (0.73 MB TIF)
Figure S3 Evaluation of the quality of the homology-modeled
CoaE model. ProQres a neural network based approach to predict
the local quality of protein structure models which uses the atom-
atom contacts, residue-residue contacts, solvent accessibility surfaces,
and secondary structure information to estimate model accuracy
over a sliding window of nine residues, showed model accuracy
scores for the minimized CoaE model mostly in the range of 0.7–1
for each consecutive window of 9 residues. The predicted model
accuracy scores range from 0 (unreliable) to 1 (reliable).
Found at: doi:10.1371/journal.pone.0007645.s004 (1.32 MB TIF)
Table S1 Sequences of primers used to clone the deletes of the
C-terminal domain
Found at: doi:10.1371/journal.pone.0007645.s005 (0.03 MB
DOC)
Table S2 Prediction of the secondary structural elements of the
mycobacterial CoaE, its N-terminal domain (NTD) and its C-
terminal domain (CTD)
Found at: doi:10.1371/journal.pone.0007645.s006 (0.03 MB
DOC)
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